Preference of acromegaly patients for treatment attributes in Spain

OBJECTIVE: Acromegaly is a rare disease caused by increased growth hormone secretion and a subsequent increase in insulin-like growth factor I (IGF-I) levels. Patients display multiple comorbidities that affect their quality of life (QoL). Treatment aims to maintain good biochemical control, tumour...

Descripción completa

Detalles Bibliográficos
Autores principales: Fajardo, Carmen, Álvarez-Escola, Cristina, Biagetti, Betina, Garcia-Centeno, Rogelio, Ciriza, Raquel, Sánchez-Cenizo, Laura, Díaz-Muñoz, Marcos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543785/
https://www.ncbi.nlm.nih.gov/pubmed/37507554
http://dx.doi.org/10.1007/s12020-023-03462-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543785/
https://www.ncbi.nlm.nih.gov/pubmed/37507554
http://dx.doi.org/10.1007/s12020-023-03462-z

Ejemplares similares